BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19267370)

  • 21. Genetic variation across C-reactive protein and risk of prostate cancer.
    Markt SC; Rider JR; Penney KL; Schumacher FR; Epstein MM; Fall K; Sesso HD; Stampfer MJ; Mucci LA
    Prostate; 2014 Jul; 74(10):1034-42. PubMed ID: 24844401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between genetic polymorphisms within IL-1B and TLR4 genes and cancer risk in a Russian population: a case-control study.
    Kutikhin AG; Yuzhalin AE; Volkov AN; Zhivotovskiy AS; Brusina EB
    Tumour Biol; 2014 May; 35(5):4821-30. PubMed ID: 24446182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.
    Tsai CW; Chang WS; Lin KC; Shih LC; Tsai MH; Hsiao CL; Yang MD; Lin CC; Bau DT
    Anticancer Res; 2014 Jul; 34(7):3731-7. PubMed ID: 24982395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population.
    Mohammadi S; Saghaeian Jazi M; Zare Ebrahimabad M; Eghbalpour F; Abdolahi N; Tabarraei A; Yazdani Y
    Int J Immunogenet; 2019 Feb; 46(1):20-30. PubMed ID: 30430731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects.
    Scarpelli D; Cardellini M; Andreozzi F; Laratta E; Hribal ML; Marini MA; Tassi V; Lauro R; Perticone F; Sesti G
    Diabetes; 2006 May; 55(5):1529-33. PubMed ID: 16644716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
    Du GH; Wang JK; Richards JR; Wang JJ
    Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
    Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
    Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Leptin gene polymorphisms and plasma leptin level in three consanguineous families with obesity.
    Fourati M; Mnif M; Kharrat N; Charfi N; Kammoun M; Fendri N; Sessi S; Abid M; Rebai A; Fakhfakh F
    Gene; 2013 Sep; 527(1):75-81. PubMed ID: 23751306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
    Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
    Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.
    Zou YF; Wang F; Feng XL; Tian YH; Tao JH; Pan FM; Huang F
    Eur J Cancer; 2011 May; 47(7):1072-9. PubMed ID: 21211963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
    Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
    PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
    Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
    World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer cachexia is associated with the IL10 -1082 gene promoter polymorphism in patients with gastroesophageal malignancy.
    Deans DA; Tan BH; Ross JA; Rose-Zerilli M; Wigmore SJ; Howell WM; Grimble RF; Fearon KC
    Am J Clin Nutr; 2009 Apr; 89(4):1164-72. PubMed ID: 19244371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.
    Bandil K; Singhal P; Dogra A; Rawal SK; Doval DC; Varshney AK; Bharadwaj M
    Inflamm Res; 2017 Dec; 66(12):1085-1097. PubMed ID: 28993831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARG and ADIPOQ gene polymorphisms increase type 2 diabetes mellitus risk in Asian Indian Sikhs: Pro12Ala still remains as the strongest predictor.
    Sanghera DK; Demirci FY; Been L; Ortega L; Ralhan S; Wander GS; Mehra NK; Singh J; Aston CE; Mulvihill JJ; Kamboh IM
    Metabolism; 2010 Apr; 59(4):492-501. PubMed ID: 19846176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
    Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
    Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL10 gene polymorphisms are associated with asthma phenotypes in children.
    Lyon H; Lange C; Lake S; Silverman EK; Randolph AG; Kwiatkowski D; Raby BA; Lazarus R; Weiland KM; Laird N; Weiss ST
    Genet Epidemiol; 2004 Feb; 26(2):155-65. PubMed ID: 14748015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
    Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
    J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.